Company
Ifmthera
At IFM Therapeutics, we work to improve the lives of patients with inflammation-driven diseases and cancer by developing transformative medicines that precisely target the innate immune system.
Also known as IFM Therapeutics, IFM Therapeutics, LLC
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Founded
- 2015
- Legal name
- IFM Therapeutics, LLC
- ifmthera.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At IFM Therapeutics, we are transforming immunotherapy to improve the lives of patients with serious diseases. We focus on developing small molecule drugs that precisely target the innate immune system, the body’s first line of immunological response.
Funding snapshot
- Total raised
- $114MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Undisclosed, $55.5M2019-11
Funding rounds
- $55.5M financing
- $55.5M2019-11, Company stated
- Series A
- $31M2018-07, Company stated
- Round, 2016
- $17.1M2016-06-17, SEC form D sold, 4 investors
- Series A
- $27M2016-06, Company stated
Loading relationship preview